|
RPRD1B expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.62436730732907E-12 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
<1E-12 |
| Normal-vs-Stage2 |
1.44750000874438E-09 |
| Normal-vs-Stage3 |
<1E-12 |
| Normal-vs-Stage4 |
1.62436730732907E-12 |
| Stage1-vs-Stage2 |
3.996800E-01 |
| Stage1-vs-Stage3 |
1.031600E-01 |
| Stage1-vs-Stage4 |
5.566200E-02 |
| Stage2-vs-Stage3 |
8.010400E-02 |
| Stage2-vs-Stage4 |
4.788400E-02 |
| Stage3-vs-Stage4 |
5.407200E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
<1E-12 |
| Normal-vs-AfricanAmerican |
1.58419999995996E-06 |
| Normal-vs-Asian |
1.94011473553246E-12 |
| Caucasian-vs-AfricanAmerican |
9.794400E-02 |
| Caucasian-vs-Asian |
8.300400E-01 |
| AfricanAmerican-vs-Asian |
2.119200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
<1E-12 |
| Normal-vs-Female |
1.62436730732907E-12 |
| Male-vs-Female |
4.426200E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.62447832963153E-12 |
| Normal-vs-Age(41-60Yrs) |
<1E-12 |
| Normal-vs-Age(61-80Yrs) |
1.62447832963153E-12 |
| Normal-vs-Age(81-100Yrs) |
1.51712999999498E-05 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
7.333400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
7.360800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.990200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
9.788400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
6.247800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.919000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
3.956500E-03 |
| Classical-VS-Follicular |
6.294400E-01 |
| Classical-VS-Other |
2.959800E-01 |
| Classical-VS-Normal |
1.67199587508549E-12 |
| Tall-VS-Follicular |
1.947800E-02 |
| Tall-VS-Other |
6.534000E-01 |
| Tall-VS-Normal |
3.33066907387547E-16 |
| Follicular-VS-Other |
4.983400E-01 |
| Follicular-VS-Normal |
1.76858527822787E-12 |
| Other-VS-Normal |
3.92620000000399E-05 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
<1E-12 |
| Normal-vs-N1 |
<1E-12 |
| N0-vs-N1 |
6.294200E-02 |
|
|
